Abstract
Protozoan parasites, such as those responsible for malaria and African Sleeping Sickness, represent a huge burden to the developing world. Current chemotherapy to combat these diseases is inadequate: antiquated, toxic and increasingly ineffective due to drug resistance. In this article, the potential usefulness of targeting key regulators of the parasite cell cycle will be discussed, paying particular attention to three families of protein kinases: Cyclin-dependent kinases, glycogen synthase kinases and Aurora kinases. This review shall outline their identification, which has been greatly accelerated by the availability of parasite genome data, their validation as bona fide regulators of the parasite cell cycle and current data on the availability and anti-parasite activity of inhibitors.
Keywords: Cyclin-dependent kinase, glycogen synthase kinase, aurora kinase, cell cycle, Trypanosoma, Leishmania, Plasmodium
Current Pharmaceutical Design
Title: Targeting the Cell Cycle in the Pursuit of Novel Chemotherapies Against Parasitic Protozoa
Volume: 14 Issue: 9
Author(s): Karen M. Grant
Affiliation:
Keywords: Cyclin-dependent kinase, glycogen synthase kinase, aurora kinase, cell cycle, Trypanosoma, Leishmania, Plasmodium
Abstract: Protozoan parasites, such as those responsible for malaria and African Sleeping Sickness, represent a huge burden to the developing world. Current chemotherapy to combat these diseases is inadequate: antiquated, toxic and increasingly ineffective due to drug resistance. In this article, the potential usefulness of targeting key regulators of the parasite cell cycle will be discussed, paying particular attention to three families of protein kinases: Cyclin-dependent kinases, glycogen synthase kinases and Aurora kinases. This review shall outline their identification, which has been greatly accelerated by the availability of parasite genome data, their validation as bona fide regulators of the parasite cell cycle and current data on the availability and anti-parasite activity of inhibitors.
Export Options
About this article
Cite this article as:
Grant M. Karen, Targeting the Cell Cycle in the Pursuit of Novel Chemotherapies Against Parasitic Protozoa, Current Pharmaceutical Design 2008; 14 (9) . https://dx.doi.org/10.2174/138161208784041042
DOI https://dx.doi.org/10.2174/138161208784041042 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Steroid Receptor-Associated Immunophilins: Candidates for Diverse Drug-Targeting Approaches in Disease
Current Molecular Pharmacology The Application of Stable Isotope Assisted Metabolomics in Biomedicine
Current Biotechnology General Considerations on the Biosafety of Virus-derived Vectors Used in Gene Therapy and Vaccination
Current Gene Therapy Empyema and Bronchopleural Fistula Following Lung Resection
Current Respiratory Medicine Reviews Cutting-edge Patents in Alzheimers Disease Drug Discovery: Anticipation of Potential Future Treatments
Recent Patents on CNS Drug Discovery (Discontinued) Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs
Current Medicinal Chemistry N-Myristoyltransferase: A Novel Target
Mini-Reviews in Medicinal Chemistry Meet Our Regional Editor
CNS & Neurological Disorders - Drug Targets Acknowledgements to Reviewers
Recent Patents on Anti-Cancer Drug Discovery Effects of Plasma Activated Medium on Head and Neck FaDu Cancerous Cells: Comparison of 3D and 2D Response
Anti-Cancer Agents in Medicinal Chemistry Pharmacological Activation of Protein Phosphatase 2 A (PP2A): A Novel Strategy to Fight Against Human Malignancies?
Current Medicinal Chemistry A Review of Pediatric Mediastinal Masses and Castlemans Disease
Current Pediatric Reviews Editorial [Hot Topic: The Pineal Hormone Melatonin in Health and Disease (Guest Editors: Charanjit Kaur)]
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) An Insight into Patents of Fluoroquinolone Derivatives
Letters in Drug Design & Discovery Inhibition of Early Biochemical Defects in Prodromal Huntington’s disease by Simultaneous Activation of Nrf2 and Elevation of Multiple Micronutrients
Current Aging Science Thymoquinone Shows the Diverse Therapeutic Actions by Modulating Multiple Cell Signaling Pathways: Single Drug for Multiple Targets
Current Pharmaceutical Biotechnology The Application of Optical Technology in Microfluidic Systems
Current Proteomics Meet Our Editorial Board Member
Letters in Drug Design & Discovery ent-Kaurane Diterpenoids from Croton tonkinensis Induce Apoptosis in Colorectal Cancer Cells through the Phosphorylation of JNK Mediated by Reactive Oxygen Species and Dual-Specificity JNK Kinase MKK4
Anti-Cancer Agents in Medicinal Chemistry Manipulation and Engineering of Metabolic and Biosynthetic Pathway of Plant Polyphenols
Current Pharmaceutical Design